Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CORRECTION: Emeren Group Q2 EPADS $0.01 Misses $0.07 Estimate, Sales $30.06M Inline

Author: Benzinga Newsdesk | August 20, 2024 09:02am

Emeren Group (NYSE:SOL) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.07 by 85.71 percent. The company reported quarterly sales of $30.06 million which met the analyst consensus estimate. This is a 133.43 percent increase over sales of $12.88 million the same period last year.

Posted In: SOL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist